CTA-31276-59259
1 vaccination
5 coded responses
11 check-ins
5 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 190 / PA
- Registered
- 2021-08-02
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-02
Registered in v-safe
-
2021-08-02
Dose 1 — Janssen/Johnson & Johnson
- 2021-08-02
-
2021-08-03
Survey response — days 1–6 daily, dose 1MedDRA: Insomnia — Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: InsomniaMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-04
- 2021-08-06
- 2021-08-09
- 2021-08-18
-
2021-08-23
Survey response — day 21, single doseMedDRA: Dizziness, Fatigue, Myalgia, Oropharyngeal pain — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Sore throat, dizziness, muscle aches, fatigueMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-30
Survey response — day 28, single doseMedDRA: Cough, Headache — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Cough and headacheMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-30
Report sent to call center — day 28, single doseGet care from a doctor or other healthcare professional1 call case(s)
- 2021-09-03
- 2021-09-13
-
2021-11-01
Survey response — 3 months, dose 1MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I had covidMedDRA releases: 2024-11 · check-in free text available
-
2021-11-01
Report sent to call center — 3 months, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-11-03
Call successfulParticipant prefers to complete VAERS report online
-
2022-08-02
Survey response — 12 months, dose 1MedDRA: Dyspnoea, Fatigue, Pain, Pyrexia, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Fever, fatigue, body aches, runny nose, congestion, shortness of breathMedDRA releases: 2024-11 · check-in free text available
-
2022-08-02
Report sent to call center — 12 months, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-08-03
Call successfulParticipant prefers to complete VAERS report online
-
2022-08-03
Call successfulDoes not wish to fill out VAERS report
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-02 | Janssen/Johnson & Johnson | No |
Call center
3 call center cases
3 successful
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Insomnia
Release 9 — day 21, single dose
Symptoms: Sore throat, dizziness, muscle aches, fatigue
Release 9 — day 28, single dose
Symptoms: Cough and headache
Release 10 — 3 months, dose 1
Symptoms: I had covid
Release 12 — 12 months, dose 1
Symptoms: Fever, fatigue, body aches, runny nose, congestion, shortness of breath
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dizziness | ✓ | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | ✓ | · | ✓ |
| SD | Headache | ✓ | · | ✓ |
| SD | Myalgia | ✓ | · | ✓ |
| SD | Oropharyngeal pain | ✓ | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Insomnia | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release